Business Context and Reporting Period
This Form 8-K is a current report filed by ChromaDex Corporation (not Niagen Bioscience, Inc.) on February 27, 2025, covering events that occurred on February 25, 2025. The filing details amendments to the employment agreement and a new equity grant for Robert Fried, the Company's Chief Executive Officer and Board member.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation adjustments.
Material Changes
- Base Salary Increase: Effective January 1, 2025, CEO Robert Fried's base salary was increased to $650,000.
- Performance Bonus Adjustment: Commencing with fiscal year 2025, Mr. Fried's target performance bonus opportunity is set at 75% of his base salary.
- Equity Grant: The Board approved a grant of 1,518,600 Performance Stock Units (PSUs) to Mr. Fried. These units vest based on achieving specific 60-day Volume Weighted Average Price (VWAP) thresholds over a seven-year performance period.
Guidance, Outlook, and Risks
Management Commentary: The Compensation Committee and Board approved the PSU grant to retain Mr. Fried and incentivize the execution of strategic priorities. The performance targets were designed to be achievable yet constitute extraordinary results for stockholders.
PSU Vesting Structure:
- $15 VWAP: 759,300 PSUs vest.
- $20 VWAP: 189,825 PSUs vest.
- $30 VWAP: 189,825 PSUs vest.
- $40 VWAP: 189,825 PSUs vest.
- $50 VWAP: 189,825 PSUs vest.
Risks and Contingencies:
- Forfeiture: Any PSUs not vested by the end of the seven-year period or upon a Change in Control will be forfeited.
- No Interpolation: There is no partial issuance for achievements between stock price thresholds, nor are there cash-out features.
- Transfer Restrictions: Vested shares are subject to transfer restrictions for five years or until a Change in Control, whichever is earlier.
- Termination Provisions: If employment is terminated without Cause or for Good Reason, unvested PSUs remain eligible to vest for 12 months, and transfer restrictions expire.
Investor Verification Checklist
- Verify the exact terms of the Amendment to the Executive Employment Agreement (Exhibit 10.1) regarding the $650,000 salary and 75% bonus target.
- Review the PSU Award Agreement (Exhibit 10.2) to confirm the specific definitions of "VWAP," "Trading Days," and "Change in Control."
- Assess the dilution impact of the potential issuance of up to 1,518,600 shares if all performance targets are met.
- Confirm the Company's current stock price relative to the $15 minimum vesting threshold to evaluate the probability of vesting.